EVALUATION OF THE EFFECTIVENESS AND SAFETY OF TWO DOSING REGIMENS OF OLOKIZUMAB (OKZ), COMPARED TO PLACEBO AND ADALIMUMAB, IN SUBJECTS WITH RHEUMATOID ARTHRITIS (RA) WHO ARE TAKING METHOTREXATE BUT HAVE ACTIVE DISEASE: